Skip to main content
Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
163.89
+0.70 (0.43%)
At close: Feb 27, 2026, 4:00 PM EST
166.00
+2.11 (1.29%)
After-hours: Feb 27, 2026, 7:10 PM EST

Axsome Therapeutics Revenue

In the year 2025, Axsome Therapeutics had annual revenue of $638.50M with 65.55% growth. Axsome Therapeutics had revenue of $196.00M in the quarter ending December 31, 2025, with 65.03% growth.

Revenue (ttm)
$638.50M
Revenue Growth
+65.55%
P/S Ratio
13.13
Revenue / Employee
$690,266
Employees
925
Market Cap
8.38B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025638.50M252.80M65.55%
Dec 31, 2024385.69M115.09M42.53%
Dec 31, 2023270.60M220.56M440.80%
Dec 31, 202250.04M--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Halozyme Therapeutics 1.40B
Bio-Techne 1.22B
Arrowhead Pharmaceuticals 1.09B
Krystal Biotech 389.13M
Cytokinetics 88.04M
Kymera Therapeutics 39.21M
Praxis Precision Medicines 7.46M
ABIVAX Société Anonyme 6.23M
Revenue Rankings

AXSM News

More News